Important Technology The technology identified for post-discharge management of congestive heart failure (CHF) and diabetes mellitus (DM) is telehomecare monitoring based on the Internet of Medical Things (IoMT). Upon discharge, a patient can put on sensing devices – glucose and electrocardiogram – to allow a nurse to check his/her vital signs remotely (ReferralMD, 2018). Thus, this technology provides a practical approach to collaborative long-term disease management in-home or community settings. What It Is IoMT describes wireless or wired infrastructure comprising medical sensors and applications that share data with hospital IT platforms (ReferralMD, 2018). Automated remote monitoring tools (RMTs) capture and transmit patient data to facility workstations via the Internet. Nurses can then review and interpret this information to track parameters like blood sugar level (DM) and electrocardiogram data (CHF). Since IoMT supports data security and interoperability, it is consistent with meaningful use requirements (stage II) meant to improve post-discharge safety and quality outcomes (McBride, Delaney, & Tietze, 2012). How It Promotes Safety IoMT is an essential technology for enhancing patient safety in chronic disease management after discharge. First, sensors worn by a patient obtain objective data that supplement subjective patient reports to support an accurate assessment of disease progression and medication efficacy (ReferralMD, 2018). Nurses can access this information from hospital computer systems to assist in transition care (Johnson & Webber, 2014). Second, IoMT supports home remote monitoring of therapy compliance and timely interventions. Electronic data capture, transmission, and review by nurses are critical in the preventive management of chronic diseases after discharge. Other ways in which IoMT promotes safety include automation of device and therapy records (reduces medical errors) and precision medicine that is optimized for each patient to minimize adverse effects (ReferralMD, 2018). Further, an inbuilt feedback system allows for disease management adjustments for optimal treatment results. Thus, IoMT enhances safety through informed clinical decisions and improved patient monitoring for better compliance with therapy, self-monitoring, etc. Why It Would Help IoMT includes devices that capture and transmit data on core physiologic parameters via the Internet. Since the client is a frequent flyer, sensors that are accessible from a wireless environment can help monitor his two conditions – CHF and DM. Further, nurses could engage him in self-monitoring of blood glucose (BG) to achieve better glycemic control. The remote surveillance of BG will indicate patient compliance with the recommended dietary regimen, exercises, insulin dosage, etc. It will also inform treatment decisions and changes to avoid symptom exacerbations (hypoglycemia or hyperglycemia) that could require readmission. For CHF, an implanted cardiac defibrillator can be used to monitor drug efficacy and weight and symptom changes in real-life settings, i.e., home or in-flight. Rapid clinical assessment and response based on data transmitted by this device can help avert sentinel events, improve the quality of li